EZH2 in Cancer Progression and Potential Application in Cancer Therapy: A Friend or Foe?

By Yan Ke-Sin   Lin Chia-Yuan   Liao Tan-Wei   Peng Cheng-Ming   Lee Shou-Chun   Liu Yi-Jui   Chan Wing P.   Chou Ruey-Hwang  

International Journal of Molecular Sciences, Vol. 18, Iss. 6, 2017-05 ,pp. : 1172-1172

MDPI

Access to resources Recommend Favorite

Is Osteopontin a Friend or Foe of Cell Apoptosis in Inflammatory Gastrointestinal and Liver Diseases?

By Iida Tomoya   Wagatsuma Kohei   Hirayama Daisuke   Nakase Hiroshi  

International Journal of Molecular Sciences, Vol. 19, Iss. 1, 2017-12 ,pp. : 7-7

MDPI

Access to resources Recommend Favorite

Candida glabrata, Friend and Foe

By Tam Phyllix   Gee Kirsten   Piechocinski Miryam   Macreadie Ian  

Journal of Fungi, Vol. 1, Iss. 2, 2015-09 ,pp. : 277-292

MDPI

Access to resources Recommend Favorite

STAT3 in Cancer—Friend or Foe?

By Zhang Hai-Feng   Lai Raymond  

Cancers, Vol. 6, Iss. 3, 2014-07 ,pp. : 1408-1440

MDPI

Access to resources Recommend Favorite

T-Cell Manipulation Strategies to Prevent Graft-Versus-Host Disease in Haploidentical Stem Cell Transplantation

By Vadakekolathu Jayakumar   Rutella Sergio  

Biomedicines, Vol. 5, Iss. 2, 2017-06 ,pp. : 33-33

MDPI

Access to resources Recommend Favorite